Monash IVF GroupMNIVF 78 5-Year RORE % is 200.00 as of Dec. 2025. GuruFocus rates MNIVF with a GF Score™ of 78/100 and a GF Value™ of $0.78. The stock has 8 warning signs investors should review. Among 182 Medical Diagnostics & Research companies, Monash IVF Group ranks better than 96.7% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Monash IVF Group's 5-Year RORE % for the quarter that ended in Dec. 2025 was 200.00%.
The industry rank for Monash IVF Group's 5-Year RORE % or its related term are showing as below:
MNIVF's 5-Year RORE % is ranked better than 96.7% of 182
companies
in the Medical Diagnostics & Research industry
Industry Median: -11.855
vs MNIVF: 200.00
Monash IVF Group (OTCPK:MNIVF) 5-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Monash IVF Group 5-Year RORE % Related Terms
Monash IVF Group 5-Year RORE % Historical Data
* Premium members only.
The historical data trend for Monash IVF Group's 5-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Monash IVF Group's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monash IVF Group 5-Year RORE % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's 5-Year RORE % distribution charts can be found below:
* The bar in red indicates where Monash IVF Group's 5-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 5-year before.
Monash IVF Group (MNIVF) has a 5-Year RORE % of 200.00 as of Dec. 2025. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Monash IVF Group and its competitors. According to the industry distribution chart, Monash IVF Group ranks #6 out of 182 companies in the Medical Diagnostics & Research industry, placing it in the top 3.3%.
Is Monash IVF Group's 5-Year RORE % too high?
Monash IVF Group's current 5-Year RORE % is 200.00. Based on the distribution chart, Monash IVF Group ranks #6 out of 182 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Monash IVF Group has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's 5-Year RORE % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Monash IVF Group ranks #6 out of 182 companies for 5-Year RORE %. This places Monash IVF Group in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year RORE % for a Medical Diagnostics & Research company?
A good 5-Year RORE % depends on the Medical Diagnostics & Research industry context. However, 5-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year RORE % mean?
A high 5-Year RORE % can signal that a stock is expensive relative to its fundamentals. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Monash IVF Group and its competitors. Monash IVF Group's current 5-Year RORE % is 200.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Monash IVF Group (MNIVF) has a current 5-Year RORE % of 200.00. The stock's GF Value™ is $0.78, compared to a current price of $0.40 — trading 48.7% below its estimated fair value. The current 5-Year RORE % is 200.00. Monash IVF Group's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year RORE % calculated?
5-Year RORE % is calculated from a company's financial statements. For Monash IVF Group (MNIVF), the current 5-Year RORE % is 200.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monash IVF Group (MNIVF) Overvalued in 2026?
Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued.
The current stock price of $0.40 is trading 48.7% below its estimated GF Value™ of $0.78.
Key valuation signals for MNIVF:
5-Year RORE %: 200.00
GF Value™: $0.78 vs. price of $0.40 (48.7% below fair value)
No single metric tells the full story. See the MNIVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
78GF Score
Get the complete analysis for MNIVF
5-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNIVF has been successfully added to your 
